In the latest research, scientists have made a breakthrough that could help users of the popular weight loss drug avoid its side effects.
This drug improves kidney function, reduces the risk of fatal heart attacks and is associated with protection against diseases such as Alzheimer’s, but many people stop using this drug simply because it is associated with common side effects such as nausea and vomiting.
Now a new weight loss drug can help reduce appetite and burn calories without causing illness.
According to experts, this discovery could offer a new treatment for millions of people suffering from obesity and type 2 diabetes, on whom existing treatments are not effective.
Millions of people around the world benefit from weight loss drugs based on the GLP-1 hormone.
In a new study, scientists at the University of Copenhagen have reported on a powerful new drug that can reduce appetite without causing muscle loss or unpleasant side effects.
Unlike existing treatments, the drug improves insulin sensitivity and increases the body’s ability to burn calories.
In the new study, published in the journal Nature, scientists tested the effects of activating a molecule called the neurokinin 2 receptor (NK2R) in mice.
The researchers found that activating this receptor not only safely increases calorie burning, but also reduces appetite without causing nausea.
